Login / Signup

[Adverse events in biologics for severe asthma].

G DargentolleM GeorgesG BeltramoC PoissonP Bonniaud
Published in: Revue des maladies respiratoires (2024)
Biologics for severe asthma are recent drugs with a favorable safety profile, but with little real-life experience, justifying increased vigilance by prescribing physicians.
Keyphrases
  • primary care
  • adverse drug